메뉴 건너뛰기




Volumn 84, Issue 12, 2009, Pages 815-820

Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; GEMTUZUMAB OZOGAMICIN; IMATINIB; RETINOIC ACID;

EID: 73349090556     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21555     Document Type: Article
Times cited : (18)

References (24)
  • 1
    • 33846007694 scopus 로고    scopus 로고
    • Treatment of relapsed acute leukemia after allogeneic transplantation: A single center experience
    • Arellano ML, Langston A, Winton E, et al. Treatment of relapsed acute leukemia after allogeneic transplantation: A single center experience. Biol Blood Marrow Transplant 2007;13:116-123.
    • (2007) Biol Blood Marrow Transplant , vol.13 , pp. 116-123
    • Arellano, M.L.1    Langston, A.2    Winton, E.3
  • 2
    • 0141707819 scopus 로고    scopus 로고
    • Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: Effect of interventions on outcome
    • Bethge WA, Storer BE, Maris MB, et al. Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: Effect of interventions on outcome. Exp Hematol 2003;31:974-980.
    • (2003) Exp Hematol , vol.31 , pp. 974-980
    • Bethge, W.A.1    Storer, B.E.2    Maris, M.B.3
  • 3
    • 2942712161 scopus 로고    scopus 로고
    • Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
    • Collins RH Jr, Shpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997;15:433-444.
    • (1997) J Clin Oncol , vol.15 , pp. 433-444
    • Collins Jr, R.H.1    Shpilberg, O.2    Drobyski, W.R.3
  • 4
    • 85121072049 scopus 로고    scopus 로고
    • Frassoni F, Barrett AJ, Granena A, et al. Relapse after allogeneic bone marrow transplantation for acute leukaemia: A survey by the E.B.M.T. of 117 cases. Br J Haematol 1988;70:317-320.
    • Frassoni F, Barrett AJ, Granena A, et al. Relapse after allogeneic bone marrow transplantation for acute leukaemia: A survey by the E.B.M.T. of 117 cases. Br J Haematol 1988;70:317-320.
  • 5
    • 0024521532 scopus 로고
    • Relapse of acute leukemia after marrow transplantation: Natural history and results of subsequent therapy
    • Mortimer J, Blinder MA, Schulman S, et al. Relapse of acute leukemia after marrow transplantation: Natural history and results of subsequent therapy. J Clin Oncol 1989;7:50-57.
    • (1989) J Clin Oncol , vol.7 , pp. 50-57
    • Mortimer, J.1    Blinder, M.A.2    Schulman, S.3
  • 6
    • 36348967686 scopus 로고    scopus 로고
    • Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
    • Oran B, Giralt S, Couriel D, et al. Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation. Leukemia 2007;21:2540-2544.
    • (2007) Leukemia , vol.21 , pp. 2540-2544
    • Oran, B.1    Giralt, S.2    Couriel, D.3
  • 7
    • 34247123624 scopus 로고    scopus 로고
    • Disease relapse after haematopoietic stem cell transplantation: Risk factors and treatment
    • Dazzi F, Fozza C. Disease relapse after haematopoietic stem cell transplantation: Risk factors and treatment. Baillieres Best Pract Res Clin Haematol 2007;20:311-327.
    • (2007) Baillieres Best Pract Res Clin Haematol , vol.20 , pp. 311-327
    • Dazzi, F.1    Fozza, C.2
  • 8
    • 0035880944 scopus 로고    scopus 로고
    • Second allogeneic bone marrow transplantation in acute leukemia: Results of a survey by the European Cooperative Group for Blood and Marrow Transplantation
    • Bosi A, Laszlo D, Labopin M, et al. Second allogeneic bone marrow transplantation in acute leukemia: Results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol 2001;19:3675-3684.
    • (2001) J Clin Oncol , vol.19 , pp. 3675-3684
    • Bosi, A.1    Laszlo, D.2    Labopin, M.3
  • 9
    • 6444220659 scopus 로고    scopus 로고
    • Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant
    • Eapen M, Giralt SA, Horowitz MM, et al. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant 2004;34:721-727.
    • (2004) Bone Marrow Transplant , vol.34 , pp. 721-727
    • Eapen, M.1    Giralt, S.A.2    Horowitz, M.M.3
  • 10
    • 22744439393 scopus 로고    scopus 로고
    • Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia
    • Hosing C, Saliba RM, Shahjahan M, et al. Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia. Bone Marrow Transplant 2005;36:157-162.
    • (2005) Bone Marrow Transplant , vol.36 , pp. 157-162
    • Hosing, C.1    Saliba, R.M.2    Shahjahan, M.3
  • 11
    • 0034092001 scopus 로고    scopus 로고
    • Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: A survey of the Societe Francaise de Greffe de moelle (SFGM)
    • Michallet M, Tanguy ML, Socie G, et al. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: A survey of the Societe Francaise de Greffe de moelle (SFGM). Br J Haematol 2000;108:400-407.
    • (2000) Br J Haematol , vol.108 , pp. 400-407
    • Michallet, M.1    Tanguy, M.L.2    Socie, G.3
  • 12
    • 0026524521 scopus 로고
    • Second HLA-identical sibling transplants for leukemia recurrence
    • Mrsic M, Horowitz MM, Atkinson K, et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 1992;9:269-275.
    • (1992) Bone Marrow Transplant , vol.9 , pp. 269-275
    • Mrsic, M.1    Horowitz, M.M.2    Atkinson, K.3
  • 13
    • 0027409544 scopus 로고
    • Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens
    • Radich JP, Sanders JE, Buckner CD, et al. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. J Clin Oncol 1993;11:304-313.
    • (1993) J Clin Oncol , vol.11 , pp. 304-313
    • Radich, J.P.1    Sanders, J.E.2    Buckner, C.D.3
  • 14
    • 0026579739 scopus 로고
    • Relapse of leukemia after bone marrow transplantation: Effect of second myeloablative therapy
    • Wagner JE, Vogelsang GB, Zehnbauer BA, et al. Relapse of leukemia after bone marrow transplantation: Effect of second myeloablative therapy. Bone Marrow Transplant 1992;9:205-209.
    • (1992) Bone Marrow Transplant , vol.9 , pp. 205-209
    • Wagner, J.E.1    Vogelsang, G.B.2    Zehnbauer, B.A.3
  • 15
    • 0031048358 scopus 로고    scopus 로고
    • Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: Results of a survey of 66 cases in 24 Japanese institutes
    • Kishi K, Takahashi S, Gondo H, et al. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: Results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant 1997;19:461-466.
    • (1997) Bone Marrow Transplant , vol.19 , pp. 461-466
    • Kishi, K.1    Takahashi, S.2    Gondo, H.3
  • 16
    • 1542753559 scopus 로고    scopus 로고
    • Revised recommendations of the International working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
    • Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003;21:4642-4649.
    • (2003) J Clin Oncol , vol.21 , pp. 4642-4649
    • Cheson, B.D.1    Bennett, J.M.2    Kopecky, K.J.3
  • 17
    • 17744419792 scopus 로고    scopus 로고
    • Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation
    • Saito K, Nakamura Y, Aoyagi M, et al. Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation. Int J Hematol 2000;71:238-244.
    • (2000) Int J Hematol , vol.71 , pp. 238-244
    • Saito, K.1    Nakamura, Y.2    Aoyagi, M.3
  • 18
    • 0028942481 scopus 로고
    • Concurrent use of granulocyte colonystimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: A pilot study
    • Yamada K, Furusawa S, Saito K, et al. Concurrent use of granulocyte colonystimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: A pilot study. Leukemia 1995;9:10-14.
    • (1995) Leukemia , vol.9 , pp. 10-14
    • Yamada, K.1    Furusawa, S.2    Saito, K.3
  • 19
    • 36348989592 scopus 로고    scopus 로고
    • Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation
    • Pollyea DA, Artz AS, Stock W, et al. Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2007;40:1027-1032.
    • (2007) Bone Marrow Transplant , vol.40 , pp. 1027-1032
    • Pollyea, D.A.1    Artz, A.S.2    Stock, W.3
  • 21
    • 0036992981 scopus 로고    scopus 로고
    • Cytoreduction, DLI, or mobilized peripheral blood progenitors
    • Kolb HJ, Schmid C, Weisser M, et al. Cytoreduction, DLI, or mobilized peripheral blood progenitors. Ann Hematol 2002;81(Suppl 2):S30-S33.
    • (2002) Ann Hematol , vol.81 , Issue.SUPPL. 2
    • Kolb, H.J.1    Schmid, C.2    Weisser, M.3
  • 22
    • 34548693215 scopus 로고    scopus 로고
    • Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation
    • Mielcarek M, Storer BE, Flowers ME, et al. Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2007;13:1160-1168.
    • (2007) Biol Blood Marrow Transplant , vol.13 , pp. 1160-1168
    • Mielcarek, M.1    Storer, B.E.2    Flowers, M.E.3
  • 23
    • 0037080121 scopus 로고    scopus 로고
    • Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation
    • Levine JE, Braun T, Penza SL, et al. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. J Clin Oncol 2002;20:405-412.
    • (2002) J Clin Oncol , vol.20 , pp. 405-412
    • Levine, J.E.1    Braun, T.2    Penza, S.L.3
  • 24
    • 0026340666 scopus 로고
    • Second transplants for leukaemic relapse after bone marrow transplantation: High early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party
    • Barrett AJ, Locatelli F, Treleaven JG, et al. Second transplants for leukaemic relapse after bone marrow transplantation: High early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party. Br J Haematol 1991;79:567-574.
    • (1991) Br J Haematol , vol.79 , pp. 567-574
    • Barrett, A.J.1    Locatelli, F.2    Treleaven, J.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.